What they were paid
Immunome Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $55,000 | $0 | $135,000 | $0 | $190,000 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immunome Inc. DEF 14A filed April 24, 2026, accession 0001140361-26-016685, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themCompensation (Chair) · Nominating/Governance
The rest of the Immunome board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Carol Schafer | Independent Director | $195,000 |
| Clay Siegall, Ph.D | Chair of the Board | $0 |
| Isaac Barchas, J.D | Lead Independent Director | $210,000 |
| Jean-Jacques Bienaim | Independent Director | — |
| Philip Wagenheim | Independent Director | $175,000 |
| Sandra Swain, M.D | Independent Director | $182,500 |
The full Immunome compensation record
free company briefThis page is one director within Immunome's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat